Tradestie Institutional Equity Comparison Engine
UNOV vs MRK โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
MRK Overall Edge
MRK Captures Institutional Edge (4โ0 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Merck & Co., Inc. (MRK) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, UNOV trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus MRK at 16.1x Forward P/E and 35.2% operating margin (+4.7% YoY). In options structure, UNOV sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against MRK sits in CONSOLIDATION (46th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
MRK
UNOV N/M vs MRK 16.1x Fwd P/E
Growth & Margin Winner
MRK
Op Margin N/A vs 35.2% ยท YoY N/A vs +4.7%
Momentum & Technical Winner
MRK
1Y +9.5% vs +55.5% ยท 52W Pos 84% vs 81%
Options & Structure Winner
MRK
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (46th %ile IV)
UNOV
Cboe BZX
Innovator U.S. Equity Ultra Buffer ETF - November
Pharmaceutical Preparations
$41.13
-0.95% 1D
Market Cap
N/A
1M Return
-0.97%
1Y Return
+9.53%
Forward P/E
N/M
Unified AI Score
58.7 / 100
HOLD
Tech 48.0
Fund 60.0
Flow 50.0
Mom 50.0
MRK
NYSE
Merck & Co., Inc.
Pharmaceutical Preparations
$144.46
-2.23% 1D
Market Cap
$364.3B
1M Return
-1.02%
1Y Return
+55.45%
Forward P/E
16.1x
Unified AI Score
56.6 / 100
HOLD
Tech 47.0
Fund 55.0
Flow 67.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
UNOV +9.53%
MRK +55.45%
Spread: +45.92 pp (MRK Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
UNOV TTM Op. Margin: N/A
MRK TTM Op. Margin: 35.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on UNOV vs MRK. Trailing 12-month operating profitability (UNOV N/A vs MRK 35.2%) and valuation multiples (UNOV N/M vs MRK 16.1x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | UNOV | MRK | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $364.3B | Larger Scale | MRK |
| Trailing P/E Ratio Valuation | N/M | 147.8x | Lower Multiple | MRK |
| Forward P/E Ratio Valuation | N/M | 16.1x | Lower Multiple | MRK |
| Revenue Growth (YoY) Growth | N/A | +4.7% | Higher Growth | MRK |
| Operating Margin (TTM) Profitability | N/A | 35.2% | Higher Margin | MRK |
| Net Profit Margin Profitability | N/A | 3.6% | Higher Margin | MRK |
| Return on Equity (ROE) Capital Efficiency | N/A | 5.1% | Higher ROE | MRK |
| 52-Week Range Position Momentum | 84% ($37โ$42) | 81% ($91โ$157) | Stronger Trend | UNOV |
| Beta / 30D Volatility Risk Regime | 0.46ฮฒ ยท 11% Vol | 0.20ฮฒ ยท 32% Vol | Lower Realized Risk | UNOV |
| Unified Institutional Score Composite Signal | 58.7 / 100 (HOLD) | 56.6 / 100 (HOLD) | Higher Composite | UNOV |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full UNOV vs MRK Buy Guide
UNOV
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
MRK
CONSOLIDATION
58d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
46th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither UNOV nor MRK registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.